Weight loss
Retatrutide 15mg
Injectable peptide for significant weight loss.
Retatrutide is a peptide targeting GLP-1, GIP, and glucagon receptors. In clinical trials it has shown superior weight loss compared to single and dual-receptor agonists, with participants losing up to 24% of body weight over 48 weeks. It works by reducing appetite, slowing gastric emptying, and increasing energy expenditure through glucagon receptor activation.
How to Use
Reconstitute the 15 mg vial with 2 mL of bacteriostatic water. Inject subcutaneously once weekly in the abdomen, thigh, or upper arm, rotating injection sites. Do not mix with other injectable medications in the same syringe.
How It Works
Retatrutide simultaneously activates three receptors involved in metabolic regulation. GLP-1 and GIP reduce appetite and slow digestion, while glucagon receptor activation increases calorie burning by boosting energy expenditure.
Common Side Effects
The most frequently reported side effects are gastrointestinal: nausea, diarrhea, vomiting, and decreased appetite, especially during dose escalation. These effects are usually temporary and tend to improve as the body adjusts. Mild injection site reactions may also occur.
Warnings
Not approved for human use. For research purposes only. Retatrutide may interact with insulin or sulfonylurea medications, increasing the risk of hypoglycemia. Do not use if you have a personal or family history of medullary thyroid carcinoma or MEN2. Consult a healthcare provider before use, especially if you have kidney problems, pancreatitis history, or are taking other medications.